Japan Ai In Oncology Market Size & Outlook, 2023-2030
Japan ai in oncology market, 2018-2030 (US$M)
Related Markets
Japan ai in oncology market highlights
- The Japan ai in oncology market generated a revenue of USD 129.0 million in 2023 and is expected to reach USD 1,047.3 million by 2030.
- The Japan market is expected to grow at a CAGR of 34.9% from 2024 to 2030.
- In terms of segment, software solutions was the largest revenue generating component in 2023.
- Software Solutions is the most lucrative component segment registering the fastest growth during the forecast period.
Ai in oncology market data book summary
| Market revenue in 2023 | USD 129.0 million |
| Market revenue in 2030 | USD 1,047.3 million |
| Growth rate | 34.9% (CAGR from 2023 to 2030) |
| Largest segment | Software solutions |
| Fastest growing segment | Software Solutions |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Software Solutions, Hardware, Services |
| Key market players worldwide | International Business Machines Corp, Siemens Healthineers AG ADR, Intel Corp, GE HealthCare Technologies Inc Common Stock, NVIDIA Corp |
Other key industry trends
- In terms of revenue, Japan accounted for 4.6% of the global ai in oncology market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China ai in oncology market is projected to lead the regional market in terms of revenue in 2030.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,047.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
AI In Oncology Market Scope
AI In Oncology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan ai in oncology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai in oncology market will help companies and investors design strategic landscapes.
Software solutions was the largest segment with a revenue share of 49.69% in 2023. Horizon Databook has segmented the Japan ai in oncology market based on software solutions, hardware, services covering the revenue growth of each sub-segment from 2018 to 2030.
Various factors driving Japan's AI in oncology market include the country's commitment to maximizing the positive impact of AI on society rather than imposing strict regulations due to perceived risks. The focus is on a risk-based, agile, and multi-stakeholder approach, providing valuable insights into global trends in AI regulation.
Moreover, collaborations and product launches between technology companies and hospitals are key drivers in Japan's AI in oncology market. These partnerships enable the utilization of clinical data and technological expertise, fostering the development and implementation of advanced AI solutions in cancer care.
Through partnerships, companies and hospitals accelerate the validation and deployment of AI-driven applications, contributing to enhanced cancer detection, diagnosis, and treatment.
Reasons to subscribe to Japan ai in oncology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan ai in oncology market databook
-
Our clientele includes a mix of ai in oncology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan ai in oncology market , including forecasts for subscribers. This country databook contains high-level insights into Japan ai in oncology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan ai in oncology market size, by component, 2018-2030 (US$M)
Japan AI In Oncology Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
